A1bg produces an antisense RNA that is under-expressed in HCC in patients with poor prognosis and reduces the malignancy of HCC cells when overexpressed [27]; Fmo3 is one of 6 lipid-metabolism-related genes that together predict the prognosis of HCC patients [28]. The gene discussed is FMO3; the disease is hepatocellular carcinoma.